We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency.AuthorsShah NP; Skaggs BJ; Branford S; Hughes TP; Nicoll JM; Paquette RL; Sawyers CLPublicationThe Journal of clinical investigation, 2007, Vol 117, Issue 9, p2562ISSN0021-9738Publication typearticleDOI10.1172/JCI30890